首页|期刊导航|中华医学杂志(英文版)|Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen
Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen
Li-Qin Sun Ting-Zhi Cao Yi-Mei Tian Man Rao Hui Wang Jia-Ye Liu Yun He Yang Zhou Liu-Mei Xu Lu-Kun Zhang Fang Zhao Xiao-Ning Liu Ying Song
中华医学杂志(英文版)2020,Vol.133Issue(23):2808-2815,8.
中华医学杂志(英文版)2020,Vol.133Issue(23):2808-2815,8.DOI:10.1097/CM9.0000000000001245
Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen
Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen
摘要
关键词
Antiretroviral therapy/Dyslipidemia/Metabolic syndrome/Non-nucleoside reverse transcriptase inhibitor/Nucleoside reverse transcriptase inhibitor/Protease inhibitorKey words
Antiretroviral therapy/Dyslipidemia/Metabolic syndrome/Non-nucleoside reverse transcriptase inhibitor/Nucleoside reverse transcriptase inhibitor/Protease inhibitor引用本文复制引用
Li-Qin Sun,Ting-Zhi Cao,Yi-Mei Tian,Man Rao,Hui Wang,Jia-Ye Liu,Yun He,Yang Zhou,Liu-Mei Xu,Lu-Kun Zhang,Fang Zhao,Xiao-Ning Liu,Ying Song..Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen[J].中华医学杂志(英文版),2020,133(23):2808-2815,8.基金项目
This work was supported by the grants from the Sanming Project of Medicine in Shenzhen[Nos.SZSM201612014 and SZSM201512029],Guangdong Basic and Applied Basic Research Foundation (No.2019A1515011197),and Science and Technology Innovation Committee of Shenzhen Municipality (No.JCYJ20190809115617365). (No.2019A1515011197)